Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability is a research paper published in The Journal of Clinical Endocrinology & Metabolism (2023). On theSindex it has a DataRank of 0.172. It has been cited 2 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
6.93 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: UL1-TR-000040
National Institutes of Health
Grant: UL1-RR-024156
Irving Institute for Clinical and Translational Research/Clinical Trials Office Pilot Award
Grant: DK112093
NIDDK NIH HHS
Grant: R21 DK112093
NCRR NIH HHS
Grant: UL1 RR024156
NCATS NIH HHS
National Center for Advancing Translational Sciences
FWCI
0.30
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals